Pleno Inc.
3 known investors
Find your way into Pleno Inc.
Sign up to see every warm intro you have to Pleno Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pleno Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pleno develops a genomic testing instrument platform designed to make multiomics testing faster, lower-cost, and higher-plex than existing methods like NGS, PCR, and microarrays. It targets clinical genomics applications such as oncology to support AI-driven precision medicine.
Investors · 3
Foresite Capital✓ confirmed by Pleno Inc.West Hollywood
How we know: Foresite Capital's portfolio page · the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us
Medical Excellence Capital✓ confirmed by Pleno Inc.New York
How we know: Medical Excellence Capital's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
Related companies · 3
NeoGenomicsNeoGenomics develops diagnostic tests and tools for cancer care, including tests for immunotherapy response monitoring, therapy selection, and minimal residual disease detection.
ZAGENO
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Companies working in the same space as Pleno Inc..
Frequently asked questions
- What does Pleno Inc. do?
- Pleno develops a genomic testing instrument platform designed to make multiomics testing faster, lower-cost, and higher-plex than existing methods like NGS, PCR, and microarrays. It targets clinical genomics applications such as oncology to support AI-driven precision medicine.
- Who are Pleno Inc.'s investors?
- Pleno Inc.'s investors include Foresite Capital, Medical Excellence Capital, Deerfield Management Company.


